Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase (original) (raw)
Complex Structure Modeling of p38 MAP Kinase and Pyridyl-pyrrole Compounds
Shuichi Miyamoto
Chem-Bio Informatics Journal, 2001
View PDFchevron_right
Dissection of the Recognition Properties of p38 MAP Kinase. Determination of the Binding Mode of a New Pyridinyl−Heterocycle Inhibitor Family
Modesto Orozco
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity
Stephen O'Keefe
Nature structural biology, 2003
View PDFchevron_right
Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity
Giovanna Scapin
Nature Structural Biology, 2003
View PDFchevron_right
The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
Mark Murcko
Chemistry & Biology, 1997
View PDFchevron_right
Pyridazine based inhibitors of p38 MAPK
Stephen O'Keefe
Bioorganic & Medicinal Chemistry Letters, 2002
View PDFchevron_right
Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796)
Jeffrey Madwed
Journal of Medicinal Chemistry, 2003
View PDFchevron_right
p38α MAP Kinase C-Terminal Domain Binding Pocket Characterized by Crystallographic and Computational Analyses
Davide Moiani
Journal of Molecular Biology, 2009
View PDFchevron_right
The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38α MAP kinase
Paul Bamborough
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
Assessment of the putative binding conformation of a pyrazolopyridine class of inhibitors of MAPKAPK2 using computational studies
Sreedhara Voleti
European Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Design, synthesis and activity of a potent, selective series of N -aryl pyridinone inhibitors of p38 kinase
Win Naing
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase
Brian Hickory, Kevin D Jerome, Jeff Hitchcock
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
Structural basis of inhibitor selectivity in MAP kinases
Sherin S. Abdel-Meguid
Structure, 1998
View PDFchevron_right
Co-crystal structure determination and cellular evaluation of 1,4-dihydropyrazolo[4,3-c] [1,2] benzothiazine 5,5-dioxide p38α MAPK inhibitors
Maria Letizia Barreca
Biochemical and Biophysical Research Communications, 2019
View PDFchevron_right
Molecular Basis for p38 Protein Kinase Inhibitor Specificity
Stephen de Laszlo
Biochemistry, 1999
View PDFchevron_right
Development of a Binding Model to Protein Tyrosine Kinases for Substituted Pyrido[2,3- d ]pyrimidine Inhibitors ‖
Hollis Showalter
Journal of Medicinal Chemistry, 1998
View PDFchevron_right
Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors
Jeffrey Tredup, Gary Schieven
Bioorganic & Medicinal Chemistry Letters, 2008
View PDFchevron_right
Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors
Stanley Chamberlain
Organic Letters, 2005
View PDFchevron_right
The Discovery of Orally Active Triaminotriazine Aniline Amides as Inhibitors of p38 MAP Kinase
jeffrey letourneau
Journal of Medicinal Chemistry, 2004
View PDFchevron_right
Effect of the distal C162S mutation on the energetics of drug binding to p38α MAP kinase
Victoria Doseeva
Archives of Biochemistry and Biophysics, 2008
View PDFchevron_right
Pyrroles and other heterocycles as inhibitors of P38 kinase
Stephen de Laszlo, Malcolm Maccoss
Bioorganic & Medicinal Chemistry Letters, 1998
View PDFchevron_right
Synthesis, Crystal Structure, and Activity of Pyrazole-Based Inhibitors of p38 Kinase
Huey Shieh
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
p38 MAP kinase inhibitors. Part 6: 2-Arylpyridazin-3-ones as templates for inhibitor design
Giovanna Scapin
Bioorganic & Medicinal Chemistry Letters, 2006
View PDFchevron_right
ACCOUNT 1564ű 1564 account Process Research and Development for Heterocyclic p38 MAP Kinase Inhibitors Heterocyclic p38 MAP Kinase Inhibitor s
ramu reddy
View PDFchevron_right
Pyrazolo[3,4- c ]pyridazines as Novel and Selective Inhibitors of Cyclin-Dependent Kinases
Ana Beatriz Rojas Ramos
Journal of Medicinal Chemistry, 2005
View PDFchevron_right
Identification of (1E, 3E)-1, 3-bis [(2-hydroxy- 1-naphthyl) methylene] Urea as Mutated MAP Kinase P38 Inhibitor through Reverse Pharmacophore Mapping Approach: Green Synthesis, Characterisation and in silico Docking analysis
Dr Inamul Hasan Madar
Indian Journal of Pharmaceutical Education and Research
View PDFchevron_right
Crystal Structure of Pyridoxal Kinase in Complex with Roscovitine and Derivatives
Stephane BACH
Journal of Biological Chemistry, 2005
View PDFchevron_right
Mechanism of action of pyridazine analogues on protein tyrosine phosphatase 1B (PTP1B)
Kurt Benkestock
Bioorganic & Medicinal Chemistry Letters, 2004
View PDFchevron_right
Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors
Gary Schieven
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
Discovery and Evaluation of 7-Alkyl-1,5-bis-aryl-pyrazolopyridinones as Highly Potent, Selective, and Orally Efficacious Inhibitors of p38α Mitogen-Activated Protein Kinase ⊥ ⊥ Atomic coordinates and structure factors for crystal structure of compound 3d with p38α can be accessed using PDB code 3LHJ
Helen McBride, Ryan Wurz
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
17. 2013_Med Chem Res.pdf
Vijay Parmar
View PDFchevron_right
Evaluation of the combination mode and features of p38 MAPK inhibitors: construction of different pharmacophore models and molecular docking
liyu zhao
Molecular Simulation, 2019
View PDFchevron_right